AVAPRO: payments to doctors
Payments that named AVAPRO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $29K
- Providers
- 4
- Transactions
- 9
- Average per transaction
- $3,188
The per-transaction average — $3,188 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $7,172, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi-aventis U.S. LLC | $28,616 | 99.7% |
| E.r. Squibb & Sons, L.L.C. | $72 | 0.3% |